D.O.T.S AINEWS
Live
OpenAI announces GPT-5 with unprecedented reasoning capabilitiesGoogle DeepMind achieves breakthrough in protein folding for rare diseasesEU passes landmark AI Safety Act with global implicationsAnthropic raises $7B as enterprise demand for Claude surgesMeta open-sources Llama 4 with 1T parameter modelNVIDIA unveils next-gen Blackwell Ultra chips for AI data centersApple integrates on-device AI across entire product lineupSam Altman testifies before Congress on AI regulation frameworkMistral AI reaches $10B valuation after Series C funding roundStability AI launches video generation model rivaling SoraOpenAI announces GPT-5 with unprecedented reasoning capabilitiesGoogle DeepMind achieves breakthrough in protein folding for rare diseasesEU passes landmark AI Safety Act with global implicationsAnthropic raises $7B as enterprise demand for Claude surgesMeta open-sources Llama 4 with 1T parameter modelNVIDIA unveils next-gen Blackwell Ultra chips for AI data centersApple integrates on-device AI across entire product lineupSam Altman testifies before Congress on AI regulation frameworkMistral AI reaches $10B valuation after Series C funding roundStability AI launches video generation model rivaling Sora

Pharma AI

1 article tagged "Pharma AI"

Eli Lilly Signs $2.75 Billion Deal With AI Drug Developer Insilico Medicine
Startups3 min read

Eli Lilly Signs $2.75 Billion Deal With AI Drug Developer Insilico Medicine

The pharmaceutical giant's landmark deal with the Hong Kong-listed AI biotech firm signals that big pharma is ready to write nine-figure checks for computational drug discovery — and that Insilico's AI-first pipeline has cleared a critical credibility threshold.

D.O.T.S AI NewsroomD.O.T.S AI Newsroom3 min read